Keynote Series Addresses Crucial Industry Issues

March 1, 2016
Rita C. Peters

Rita Peters is editorial director of BioPharm International, Pharmaceutical Technology, and Pharmaceutical Technology Europe.

Volume 29, Issue 3
Page Number: 6

Thought leaders tackle drug shortages and biomanufacturing challenges.

At INTERPHEX 2016 at the Javits Center in New York, BioPharm International and Pharmaceutical Technology will host a Keynote Series on leading bio/pharma industry issues. Sessions will be presented on the Innovation Stage in the exhibit hall. Admission is free to any attendee with an exhibit hall pass. The following is a preview of the topics.

Overcoming Bottlenecks in Biopharmaceutical Development
In a panel discussion, industry experts will discuss how technology advances are addressing challenges in biopharmaceutical development including quality control of raw materials, implementation of single-use technologies, process monitoring, and downstream purification. The panelists are Marian L. McKee, PhD, director, US development services, MilliporeSigma; Mike Goodwin, director of R&D, SUT, Thermo Fisher Scientific; Alex Perieteanu, PhD, director, biopharmaceutical services-Life Sciences, SGS Mississauga; Elizabeth Goodrich, director of applications engineering, MilliporeSigma.
(Tuesday, April 26, 10:15-11:45 am)

Contract Services Market: 2016 Update
How will consolidation in the bio/pharmaceutical and contract services market, a changing financial market, and an active political and regulatory year shape the fortunes of the contract services market? In his annual presentation, Jim Miller, founder and president, PharmSource Information Services will offer his perspectives on the contract services landscape for the next few years.
(Wednesday, April 27, 10:30-11:30 am)

Strategies and Innovations to Reduce Drug Shortages and Improve Availability of Medicines 
Aging facilities and equipment, inadequate operator training, a lack of quality control, tighter regulatory enforcement, and business decisions to eliminate unprofitable product lines contribute to ongoing shortages of vital drug products. In this session, industry thought leaders will identify triggers for drug shortages, methods to avoid production line shutdowns and update facilities, and innovative industry efforts to fulfill demand for needed therapies.
(Wednesday, April 27, 1:30-3:15 pm)

An Interdisciplinary Approach to Address Drug Shortages. The effects of drug shortages on patients, caregivers, hospitals, and medical professionals are often not observed or understood by the bio/pharmaceutical manufacturing segment. This presentation will explore alternative, innovative, and cost-effective ways to provide needed therapies to patients.

BARDA Innovation Initiatives in Medical Countermeasure Manufacturing. This presentation will describe the Biomedical Advanced Research and Development Authority’s (BARDA) program initiatives in manufacturing technologies for medical countermeasure advanced development, including opportunities with the Centers for Innovation in Advanced Development & Manufacturing and in continuous manufacturing.

Panel Discussion: Addressing Sterile Manufacturing Challenges 
Sterile injectables have been in extremely short supply, and industry efforts have been focusing on root causes involving infrastructure, quality, and efficiency. Experts involved in this work discuss recent initiatives, and offer insights into what must be done to prevent injectables shortages in the future.
(Wednesday, April 27, 3:30-4:30 pm)

For more information about the Keynote Series, including sessions for small-molecule manufacturing, visit: www.biopharminternational.com/bp/Interphex2016.

 

Article Details
BioPharm International
Vol. 29, No. 3
Pages: 6
Citation: When referring to this article, please cite it as R. Peters, " Keynote Series Addresses Crucial Industry Issues," BioPharm International 29 (3) 2016.